Changing environment of hyperglycemia in pregnancy: Gestational diabetes and diabetes mellitus in pregnancy.

{"article_title":"Changing environment of hyperglycemia in pregnancy: Gestational diabetes and diabetes mellitus in pregnancy.","author":"Gray SG, Sweeting AN, Mcguire TM, Cohen N, Ross GP, Little PJ","journal_title":"Journal of diabetes","issn":"1753-0407","isbn":"","publication_date":"2018 Aug","volume":"10","issue":"8","first_page":"633","page_count":"","accession_number":"29573162","doi":"10.1111\/1753-0407.12660","publisher":"Blackwell Publishing Asia","doctype":"Journal Article","subjects":"Diabetes, Gestational diagnosis; Diabetes, Gestational drug therapy; Hyperglycemia diagnosis; Adult; Female; Humans; Hyperglycemia drug therapy; Hypoglycemic Agents therapeutic use; Infant, Newborn; Metformin therapeutic use; Pregnancy; Pregnancy Outcome","interest_area":["Obstetrics & Gynecology"," Endocrinology"],"abstract":"The diagnosis and treatment of gestational diabetes mellitus (GDM) have been in a state of flux since the World Health Organization accepted and endorsed the International Diabetes and Pregnancy Study Group's diagnostic pathway and criteria in 2013. These new diagnostic criteria identify an increasing number of women at risk of hyperglycemia in pregnancy (HGiP). Maternal hyperglycemia represents a significant risk to the mother and fetus, in both the short and long term. Controversially, metformin use for the treatment of GDM is increasing in Australia. This article identifies the multiple and varied presentations of HGiP, of which GDM is the most commonly encountered. The degree of maternal hyperglycemia experienced affects the outcomes for both the mother and neonate, and specific diagnosis determines the appropriate treatment for the pregnancy. Given the increasing incidence of women with dysglycemia and those developing HGiP, this is an important area for research and clinical attention for all health professionals. \ufffd 2018 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=29573162&authtype=shib&custid=ns346513","isPdfLink":true,"isSAML":false,"additionalInfo":{"Authored_By":"Gray SG, Sweeting AN, Mcguire TM, Cohen N, Ross GP, Little PJ","Journal_Info":"Publisher: Blackwell Publishing Asia Country of Publication: Australia NLM ID: 101504326 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1753-0407 (Electronic) Linking ISSN: 17530407 NLM ISO Abbreviation: J Diabetes Subsets: MEDLINE","Publication_Type":"Journal Article; Review","Published_Date":"2018-08-01","Source":"Journal of diabetes [J Diabetes] 2018 Aug; Vol. 10 (8), pp. 633-640. Date of Electronic Publication: 2018 Apr 26.","Languages":"English","Electronic_ISSN":"1753-0407","MeSH_Terms":"Diabetes, Gestational\/*diagnosis , Diabetes, Gestational\/*drug therapy , Hyperglycemia\/*diagnosis, Adult ; Female ; Humans ; Hyperglycemia\/drug therapy ; Hypoglycemic Agents\/therapeutic use ; Infant, Newborn ; Metformin\/therapeutic use ; Pregnancy ; Pregnancy Outcome","Subjects":"Adult, Female, Humans, Hyperglycemia drug therapy, Hypoglycemic Agents therapeutic use, Infant, Newborn, Metformin therapeutic use, Pregnancy, Pregnancy Outcome, Diabetes, Gestational diagnosis, Diabetes, Gestational drug therapy, Hyperglycemia diagnosis","Title_Abbreviations":"Journal of diabetes","Volume":"10"},"header":{"DbId":"mdl","DbLabel":"MEDLINE Ultimate","An":"29573162","RelevancyScore":"821","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"821.228881835938"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=29573162&authtype=shib&custid=ns346513&group=main&profile=eds","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=29573162&authtype=shib&custid=ns346513&group=main&profile=eds"}